UCDHSC和Source MDx合作研发皮肤病分子诊断方法

 
 
Colorado大学Denver健康科学中心(UCDHSC, Denver, CO, USA)和Source MDx (Boulder, CO, USA)已经达成了一项研究合作计划，开发皮肤疾病早期诊断和预后的分子学诊断方法，包括黑色素瘤和牛皮癣。

恶性黑色素瘤进展迅速危及生命的皮肤癌，极易转移至身体其他部位。Mayumi Fujita博士是Colorado大学医学院皮肤科的助理教授，他说：“黑色素瘤早期诊断和准确分级是治疗的关键，将会发生转移的患者鉴别出来，是对指导制定治疗方案是十分重要的，恶性黑色素瘤在转移之前是能够治疗的疾病。”

Collaboration to Develop Molecular Tests for Skin Diseases
 
The University of Colorado at Denver Health Sciences Center (UCDHSC, Denver, CO, USA) and Source MDx (Boulder, CO, USA) have entered into a research collaboration to develop molecular diagnostic tests for early diagnosis and prognosis of skin diseases, including melanoma and psoriasis.

Malignant melanoma is the most aggressive and life-threatening skin cancer and has a high tendency to spread to other parts of the body. “Early detection and accurate staging of melanoma is critical to the management of melanoma, and identifying the patients who will show progression to metastatic disease is important to direct an appropriate treatment regimen,” said Mayumi Fujita, M.D., Ph.D., assistant professor in the department of dermatology at the University of Colorado School of Medicine. “Malignant melanoma, when detected prior to progression, is a highly curable malignancy.”